{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:39:22Z","timestamp":1790199562505,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T00:00:00Z","timestamp":1381968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s40265-013-0128-x","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T07:54:11Z","timestamp":1381910051000},"page":"1749-1759","source":"Crossref","is-referenced-by-count":21,"title":["Preventing Postoperative Recurrence in Crohn\u2019s Disease: What Does the Future Hold?"],"prefix":"10.1007","volume":"73","author":[{"given":"Lucine","family":"Vuitton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Peyrin-Biroulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,17]]},"reference":[{"key":"128_CR1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ajg.2009.579","volume":"105","author":"L Peyrin-Biroulet","year":"2010","unstructured":"Peyrin-Biroulet L, Loftus EV Jr, Colombel J-F, et al. The natural history of adult Crohn\u2019s disease in population-based cohorts. Am J Gastroenterol. 2010;105:289\u201397.","journal-title":"Am J Gastroenterol"},{"key":"128_CR2","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/gut.2010.234617","volume":"60","author":"G Bouguen","year":"2011","unstructured":"Bouguen G, Peyrin-Biroulet L. Surgery for adult Crohn\u2019s disease: what is the actual risk? Gut. 2011;60:1178\u201381.","journal-title":"Gut"},{"key":"128_CR3","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/ajg.2012.298","volume":"107","author":"L Peyrin-Biroulet","year":"2012","unstructured":"Peyrin-Biroulet L, Harmsen WS, Tremaine WJ, et al. Surgery in a population-based cohort of Crohn\u2019s disease from Olmsted County, Minnesota (1970\u20132004). Am J Gastroenterol. 2012;107:1693\u2013701.","journal-title":"Am J Gastroenterol"},{"key":"128_CR4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2036.2012.05002.x","volume":"35","author":"A Buisson","year":"2012","unstructured":"Buisson A, Chevaux J-B, Allen PB, Bommelaer G, et al. Review article: the natural history of postoperative Crohn\u2019s disease recurrence. Aliment Pharmacol Ther. 2012;35:625\u201333.","journal-title":"Aliment Pharmacol Ther"},{"key":"128_CR5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ibd.21355","volume":"17","author":"M Regueiro","year":"2011","unstructured":"Regueiro M, Kip KE, Schraut W, et al. Crohn\u2019s disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection. Inflamm Bowel Dis. 2011;17:118\u201326.","journal-title":"Inflamm Bowel Dis"},{"key":"128_CR6","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0016-5085(90)90613-6","volume":"99","author":"P Rutgeerts","year":"1990","unstructured":"Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn\u2019s disease. Gastroenterology. 1990;99:956\u201363.","journal-title":"Gastroenterology"},{"key":"128_CR7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.crohns.2009.09.009","volume":"4","author":"G Assche Van","year":"2010","unstructured":"Van Assche G, Dignass A, Reinisch W, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn\u2019s disease: Special situations. J Crohns Colitis. 2010;4:63\u2013101.","journal-title":"J Crohns Colitis"},{"key":"128_CR8","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1365-2036.2004.02245.x","volume":"20","author":"F Parente","year":"2004","unstructured":"Parente F, Sampietro GM, Molteni M, et al. Behaviour of the bowel wall during the first year after surgery is a strong predictor of symptomatic recurrence of Crohn\u2019s disease: a prospective study. Aliment Pharmacol Ther. 2004;20:959\u201368.","journal-title":"Aliment Pharmacol Ther"},{"key":"128_CR9","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/ibd.20469","volume":"14","author":"F Castiglione","year":"2008","unstructured":"Castiglione F, Bucci L, Pesce G, et al. Oral contrast-enhanced sonography for the diagnosis and grading of postsurgical recurrence of Crohn\u2019s disease. Inflamm Bowel Dis. 2008;14:1240\u20135.","journal-title":"Inflamm Bowel Dis"},{"key":"128_CR10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ibd.21003","volume":"16","author":"S Koilakou","year":"2010","unstructured":"Koilakou S, Sailer J, Peloschek P, et al. Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn\u2019s disease after ileocolic resection. Inflamm Bowel Dis. 2010;16:198\u2013203.","journal-title":"Inflamm Bowel Dis"},{"key":"128_CR11","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/ibd.20199","volume":"13","author":"L Biancone","year":"2007","unstructured":"Biancone L, Calabrese E, Petruzziello C, et al. Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn\u2019s disease. Inflamm Bowel Dis. 2007;13:1256\u201365.","journal-title":"Inflamm Bowel Dis"},{"key":"128_CR12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.gie.2006.12.059","volume":"66","author":"V Pons Beltr\u00e1n","year":"2007","unstructured":"Pons Beltr\u00e1n V, Nos P, Bastida G, et al. Evaluation of postsurgical recurrence in Crohn\u2019s disease: a new indication for capsule endoscopy? Gastrointest Endosc. 2007;66:533\u201340.","journal-title":"Gastrointest Endosc"},{"key":"128_CR13","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.cgh.2007.09.002","volume":"5","author":"IC Solberg","year":"2007","unstructured":"Solberg IC, Vatn MH, H\u00f8ie O, et al. Clinical course in Crohn\u2019s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5:1430\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"128_CR14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/gut.26.2.146","volume":"26","author":"V Binder","year":"1985","unstructured":"Binder V, Hendriksen C, Kreiner S. Prognosis in Crohn\u2019s disease\u2014based on results from a regional patient group from the county of Copenhagen. Gut. 1985;26:146\u201350.","journal-title":"Gut"},{"key":"128_CR15","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00384-008-0542-9","volume":"23","author":"GE Reese","year":"2008","unstructured":"Reese GE, Nanidis T, Borysiewicz C, et al. The effect of smoking after surgery for Crohn\u2019s disease: a meta-analysis of observational studies. Int J Colorectal Dis. 2008;23:1213\u201321.","journal-title":"Int J Colorectal Dis"},{"key":"128_CR16","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0016-5085(98)70419-6","volume":"114","author":"A Timmer","year":"1998","unstructured":"Timmer A, Sutherland LR, Martin F. Oral contraceptive use and smoking are risk factors for relapse in Crohn\u2019s disease. The Canadian Mesalamine for Remission of Crohn\u2019s Disease Study Group. Gastroenterology. 1998;114:1143\u201350.","journal-title":"Gastroenterology"},{"key":"128_CR17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/MEG.0b013e328326a01e","volume":"21","author":"SC Ng","year":"2009","unstructured":"Ng SC, Lied GA, Arebi N, et al. Clinical and surgical recurrence of Crohn\u2019s disease after ileocolonic resection in a specialist unit. Eur J Gastroenterol Hepatol. 2009;21:551\u20137.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"128_CR18","first-page":"1","volume":"490","author":"G Hellers","year":"1979","unstructured":"Hellers G. Crohn\u2019s disease in Stockholm county 1955\u20131974. A study of epidemiology, results of surgical treatment and long-term prognosis. Acta Chir Scand Suppl. 1979;490:1\u201384.","journal-title":"Acta Chir Scand Suppl"},{"key":"128_CR19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1572-0241.2007.01548.x","volume":"103","author":"C Simillis","year":"2008","unstructured":"Simillis C, Yamamoto T, Reese GE, et al. A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn\u2019s disease. Am J Gastroenterol. 2008;103:196\u2013205.","journal-title":"Am J Gastroenterol"},{"key":"128_CR20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/gut.29.5.588","volume":"29","author":"AJ Greenstein","year":"1988","unstructured":"Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and non-perforating indications for repeated operations in Crohn\u2019s disease: evidence for two clinical forms. Gut. 1988;29:588\u201392.","journal-title":"Gut"},{"key":"128_CR21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00000658-200001000-00006","volume":"231","author":"O Bernell","year":"2000","unstructured":"Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn\u2019s disease. Ann Surg. 2000;231:38\u201345.","journal-title":"Ann Surg"},{"key":"128_CR22","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/0016-5085(90)90324-T","volume":"98","author":"LR Sutherland","year":"1990","unstructured":"Sutherland LR, Ramcharan S, Bryant H, et al. Effect of cigarette smoking on recurrence of Crohn\u2019s disease. Gastroenterology. 1990;98:1123\u20138.","journal-title":"Gastroenterology"},{"key":"128_CR23","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.3748\/wjg.v11.i3.412","volume":"11","author":"T Yamamoto","year":"2005","unstructured":"Yamamoto T. Factors affecting recurrence after surgery for Crohn\u2019s disease. World J Gastroenterol. 2005;11:3971\u20139.","journal-title":"World J Gastroenterol"},{"key":"128_CR24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2036.2011.04932.x","volume":"35","author":"A Eser","year":"2012","unstructured":"Eser A, Papay P, Primas C, et al. The impact of intestinal resection on serum levels of anti-Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn\u2019s disease. Aliment Pharmacol Ther. 2012;35:292\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"128_CR25","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1053\/j.gastro.2006.02.025","volume":"130","author":"M Ferrante","year":"2006","unstructured":"Ferrante M, de Hertogh G, Hlavaty T, et al. The value of myenteric plexitis to predict early postoperative Crohn\u2019s disease recurrence. Gastroenterology. 2006;130:1595\u2013606.","journal-title":"Gastroenterology"},{"key":"128_CR26","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/gut.2009.177782","volume":"58","author":"H Sokol","year":"2009","unstructured":"Sokol H, Polin V, Lavergne-Slove A, et al. Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn\u2019s disease. Gut. 2009;58:1218\u201325.","journal-title":"Gut"},{"key":"128_CR27","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/MIB.0b013e318281f336","volume":"19","author":"A Bressenot","year":"2013","unstructured":"Bressenot A, Chevaux J-B, Williet N, et al. Submucosal plexitis as a predictor of postoperative surgical recurrence in Crohn\u2019s disease. Inflamm Bowel Dis. 2013;19:1654\u201361.","journal-title":"Inflamm Bowel Dis"},{"key":"128_CR28","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/ibd.20932","volume":"15","author":"SC Ng","year":"2009","unstructured":"Ng SC, Lied GA, Kamm MA, Sandhu F, et al. Predictive value and clinical significance of myenteric plexitis in Crohn\u2019s disease. Inflamm Bowel Dis. 2009;15:1499\u2013507.","journal-title":"Inflamm Bowel Dis"},{"key":"128_CR29","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1053\/j.gastro.2008.07.066","volume":"135","author":"S Renna","year":"2008","unstructured":"Renna S, Camm\u00e0 C, Modesto I, et al. Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn\u2019s disease. Gastroenterology. 2008;135:1500\u20139.","journal-title":"Gastroenterology"},{"key":"128_CR30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0016-5085(95)90059-4","volume":"108","author":"C Brignola","year":"1995","unstructured":"Brignola C, Cottone M, Pera A, et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn\u2019s disease. Italian Cooperative Study Group. Gastroenterology. 1995;108:345\u20139.","journal-title":"Gastroenterology"},{"key":"128_CR31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0016-5085(95)90327-5","volume":"109","author":"RS McLeod","year":"1995","unstructured":"McLeod RS, Wolff BG, Steinhart AH, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn\u2019s disease. Gastroenterology. 1995;109:404\u201313.","journal-title":"Gastroenterology"},{"key":"128_CR32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00042737-199603000-00008","volume":"8","author":"C Florent","year":"1996","unstructured":"Florent C, Cortot A, Quandale P, et al. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn\u2019s disease. Groupe d\u2019Etudes Th\u00e9rapeutiques des Affections Inflammatoires Digestives (GETAID). Eur J Gastroenterol Hepatol. 1996;8:229\u201333.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"128_CR33","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0016-5085(00)70208-3","volume":"118","author":"H Lochs","year":"2000","unstructured":"Lochs H, Mayer M, Fleig WE, et al. Prophylaxis of postoperative relapse in Crohn\u2019s disease with mesalamine: European Cooperative Crohn\u2019s Disease Study VI. Gastroenterology. 2000;118:264\u201373.","journal-title":"Gastroenterology"},{"key":"128_CR34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/j.gastro.2004.06.002","volume":"127","author":"SB Hanauer","year":"2004","unstructured":"Hanauer SB, Korelitz BI, Rutgeerts P, et al. Postoperative maintenance of Crohn\u2019s disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology. 2004;127:723\u20139.","journal-title":"Gastroenterology"},{"key":"128_CR35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2036.1994.tb00158.x","volume":"8","author":"R Caprilli","year":"1994","unstructured":"Caprilli R, Andreoli A, Capurso L, et al. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn\u2019s disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther. 1994;8:35\u201343.","journal-title":"Aliment Pharmacol Ther"},{"key":"128_CR36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2036.2003.01462.x","volume":"17","author":"R Caprilli","year":"2003","unstructured":"Caprilli R, Cottone M, Tonelli F, et al. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn\u2019s disease: a pragmatic, double-blind, randomized controlled trial. Aliment Pharmacol Ther. 2003;17:517\u201323.","journal-title":"Aliment Pharmacol Ther"},{"key":"128_CR37","doi-asserted-by":"crossref","unstructured":"Doherty G, Bennett G, Patil S, et al. Interventions for prevention of post-operative recurrence of Crohn\u2019s disease. Cochrane Database Syst Rev. 2009;(4):CD006873.","DOI":"10.1002\/14651858.CD006873.pub2"},{"key":"128_CR38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000199850","volume":"42","author":"K Ewe","year":"1989","unstructured":"Ewe K, Herfarth C, Malchow H, et al. Postoperative recurrence of Crohn\u2019s disease in relation to radicality of operation and sulfasalazine prophylaxis: a multicenter trial. Digestion. 1989;42:224\u201332.","journal-title":"Digestion"},{"key":"128_CR39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00042737-199903000-00011","volume":"11","author":"K Ewe","year":"1999","unstructured":"Ewe K, B\u00f6ttger T, Buhr HJ, et al. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn\u2019s disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol. 1999;11:277\u201382.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"128_CR40","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0016-5085(99)70125-3","volume":"116","author":"G Hellers","year":"1999","unstructured":"Hellers G, Cortot A, Jewell D, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn\u2019s disease. The IOIBD Budesonide Study Group. Gastroenterology. 1999;116:294\u2013300.","journal-title":"Gastroenterology"},{"key":"128_CR41","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0016-5085(95)90121-3","volume":"108","author":"P Rutgeerts","year":"1995","unstructured":"Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn\u2019s recurrence after ileal resection. Gastroenterology. 1995;108:1617\u201321.","journal-title":"Gastroenterology"},{"key":"128_CR42","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.gastro.2005.01.010","volume":"128","author":"P Rutgeerts","year":"2005","unstructured":"Rutgeerts P, Van Assche G, Vermeire S, et al. Ornidazole for prophylaxis of postoperative Crohn\u2019s disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2005;128:856\u201361.","journal-title":"Gastroenterology"},{"key":"128_CR43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ibd.20063","volume":"13","author":"A Gossum Van","year":"2007","unstructured":"Van Gossum A, Dewit O, Louis E, et al. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn\u2019s disease after lleo-caecal resection. Inflamm Bowel Dis. 2007;13:135\u201342.","journal-title":"Inflamm Bowel Dis"},{"key":"128_CR44","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/gut.2005.076604","volume":"55","author":"P Marteau","year":"2006","unstructured":"Marteau P, L\u00e9mann M, Seksik P, et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn\u2019s disease: a randomised, double blind, placebo controlled GETAID trial. Gut. 2006;55:842\u20137.","journal-title":"Gut"},{"key":"128_CR45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/gut.51.3.405","volume":"51","author":"C Prantera","year":"2002","unstructured":"Prantera C, Scribano ML, Falasco G, et al. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn\u2019s disease: a randomised controlled trial with Lactobacillus GG. Gut. 2002;51:405\u20139.","journal-title":"Gut"},{"key":"128_CR46","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10620-006-9549-7","volume":"52","author":"I Chermesh","year":"2007","unstructured":"Chermesh I, Tamir A, Reshef R, et al. Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn\u2019s disease. Dig Dis Sci. 2007;52:385\u20139.","journal-title":"Dig Dis Sci"},{"issue":"Suppl 1","key":"128_CR47","first-page":"A361","volume":"134","author":"K Madsen","year":"2008","unstructured":"Madsen K, Backer JL, Leddin D, et al. A randomized controlled trial of VSL#3 for, the prevention of endoscopic recurrence following surgery, for Crohn\u2019s disease. Gastroenterology. 2008;134(Suppl 1):A361.","journal-title":"Gastroenterology"},{"key":"128_CR48","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2036.2010.04231.x","volume":"31","author":"GA Doherty","year":"2010","unstructured":"Doherty GA, Bennett GC, Cheifetz AS, et al. Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn\u2019s disease. Aliment Pharmacol Ther. 2010;31:802\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"128_CR49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2036.2006.03158.x","volume":"25","author":"T Yamamoto","year":"2007","unstructured":"Yamamoto T, Nakahigashi M, Umegae S, et al. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn\u2019s disease: a prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther. 2007;25:67\u201372.","journal-title":"Aliment Pharmacol Ther"},{"key":"128_CR50","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00384-012-1587-3","volume":"28","author":"T Yamamoto","year":"2013","unstructured":"Yamamoto T, Shiraki M, Nakahigashi M, et al. Enteral nutrition to suppress postoperative Crohn\u2019s disease recurrence: a five-year prospective cohort study. Int J Colorectal Dis. 2013;28:335\u201340.","journal-title":"Int J Colorectal Dis"},{"key":"128_CR51","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1080\/00365520510023729","volume":"40","author":"M Esaki","year":"2005","unstructured":"Esaki M, Matsumoto T, Hizawa K, et al. Preventive effect of nutritional therapy against postoperative recurrence of Crohn disease, with reference to findings determined by intra-operative enteroscopy. Scand J Gastroenterol. 2005;40:1431\u20137.","journal-title":"Scand J Gastroenterol"},{"key":"128_CR52","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.gastro.2004.06.051","volume":"127","author":"S Ardizzone","year":"2004","unstructured":"Ardizzone S, Maconi G, Sampietro GM, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn\u2019s disease. Gastroenterology. 2004;127:730\u201340.","journal-title":"Gastroenterology"},{"key":"128_CR53","first-page":"1525","volume":"55","author":"H Herfarth","year":"2006","unstructured":"Herfarth H, Tjaden C, Lukas M, et al. Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn\u2019s disease. Gut. 2006;55:1525\u20136.","journal-title":"Gut"},{"key":"128_CR54","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1053\/j.gastro.2008.07.010","volume":"135","author":"GR D\u2019Haens","year":"2008","unstructured":"D\u2019Haens GR, Vermeire S, Van Assche G, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn\u2019s disease: a controlled randomized trial. Gastroenterology. 2008;135:1123\u20139.","journal-title":"Gastroenterology"},{"key":"128_CR55","first-page":"374","volume":"23","author":"P Nos","year":"2000","unstructured":"Nos P, Hinojosa J, Aguilera V, et al. Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn\u2019s disease. Gastroenterol Hepatol. 2000;23:374\u20138.","journal-title":"Gastroenterol Hepatol"},{"key":"128_CR56","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1038\/ajg.2009.301","volume":"104","author":"L Peyrin-Biroulet","year":"2009","unstructured":"Peyrin-Biroulet L, Deltenre P, Ardizzone S, et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn\u2019s disease: a meta-analysis. Am J Gastroenterol. 2009;104:2089\u201396.","journal-title":"Am J Gastroenterol"},{"key":"128_CR57","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1053\/j.gastro.2008.10.051","volume":"136","author":"M Regueiro","year":"2009","unstructured":"Regueiro M, Schraut W, Baidoo L, et al. Infliximab prevents Crohn\u2019s disease recurrence after ileal resection. Gastroenterology. 2009;136:441\u201350.","journal-title":"Gastroenterology"},{"key":"128_CR58","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1007\/s10620-011-1785-9","volume":"56","author":"M Regueiro","year":"2011","unstructured":"Regueiro M, El-Hachem S, Kip KE, et al. Postoperative infliximab is not associated with an increase in adverse events in Crohn\u2019s disease. Dig Dis Sci. 2011;56:3610\u20135.","journal-title":"Dig Dis Sci"},{"key":"128_CR59","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/ibd.21928","volume":"18","author":"K Yoshida","year":"2012","unstructured":"Yoshida K, Fukunaga K, Ikeuchi H, et al. Scheduled infliximab monotherapy to prevent recurrence of Crohn\u2019s disease following ileocolic or ileal resection: a 3-year prospective randomized open trial. Inflamm Bowel Dis. 2012;18:1617\u201323.","journal-title":"Inflamm Bowel Dis"},{"key":"128_CR60","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1001\/archinte.167.16.1804","volume":"167","author":"D Sorrentino","year":"2007","unstructured":"Sorrentino D, Terrosu G, Avellini C, et al. Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. Arch Intern Med. 2007;167:1804\u20137.","journal-title":"Arch Intern Med"},{"key":"128_CR61","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cgh.2010.01.016","volume":"8","author":"D Sorrentino","year":"2010","unstructured":"Sorrentino D, Paviotti A, Terrosu G, et al. Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn\u2019s disease. Clin Gastroenterol Hepatol. 2010;8:591\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"128_CR62","doi-asserted-by":"crossref","unstructured":"Regueiro M, Baidoo L, Kip KE, et al. Infliximab maintenance beyond one year prevents postoperative Crohn\u2019s disease recurrence: long-term follow-up from the randomized controlled pilot study. Gastroenterology. 2013;144(Suppl1):S-173.","DOI":"10.1016\/S0016-5085(13)60618-6"},{"key":"128_CR63","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.3748\/wjg.v18.i32.4391","volume":"18","author":"M Aguas","year":"2012","unstructured":"Aguas M, Bastida G, Cerrillo E, et al. Adalimumab in prevention of postoperative recurrence of Crohn\u2019s disease in high-risk patients. World J Gastroenterol. 2012;18:4391\u20138.","journal-title":"World J Gastroenterol"},{"key":"128_CR64","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.crohns.2012.02.012","volume":"6","author":"K Papamichael","year":"2012","unstructured":"Papamichael K, Archavlis E, Lariou C, et al. Adalimumab for the prevention and\/or treatment of post-operative recurrence of Crohn\u2019s disease: a prospective, two-year, single center, pilot study. J Crohns Colitis. 2012;6:924\u201331.","journal-title":"J Crohns Colitis"},{"key":"128_CR65","doi-asserted-by":"crossref","unstructured":"De Cruz P, Kamm MA, Hamilton AL, et al. Optimising post-operative Crohn\u2019s disease management: best drug therapy alone versus colonoscopic monitoring with treatment step-up. The POCER study. Gastroenterology. 2013;144(Suppl):S-164.","DOI":"10.1016\/S0016-5085(13)60588-0"},{"key":"128_CR66","doi-asserted-by":"crossref","unstructured":"Savarino E, Bodini G, Dulbecco P, et al. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn\u2019s disease\u2014a randomized trial. Gastroenterology. 2013;144(Suppl):S-21.","DOI":"10.1016\/S0016-5085(13)60072-4"},{"key":"128_CR67","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ajg.2008.168","volume":"104","author":"GR Lichtenstein","year":"2009","unstructured":"Lichtenstein GR, Hanauer SB, Sandborn WJ. Practice Parameters Committee of American College of Gastroenterology. Management of Crohn\u2019s disease in adults. Am J Gastroenterol. 2009;104:465\u201383.","journal-title":"Am J Gastroenterol"},{"key":"128_CR68","unstructured":"National Institute for Health and Care Excellence (NICE). NICE guideline on Crohn\u2019s disease. http:\/\/www.bsg.org.uk\/clinical-guidelines\/ibd\/2012-nice-guideline-on-crohn-s-disease.html (Accessed 21 Sep 2013)."},{"key":"128_CR69","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/ibd.21904","volume":"18","author":"GA Doherty","year":"2012","unstructured":"Doherty GA, Miksad RA, Cheifetz AS, et al. Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn\u2019s disease. Inflamm Bowel Dis. 2012;18:1608\u201316.","journal-title":"Inflamm Bowel Dis"},{"key":"128_CR70","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1038\/ajg.2011.237","volume":"106","author":"AN Ananthakrishnan","year":"2011","unstructured":"Ananthakrishnan AN, Hur C, Juillerat P, et al. Strategies for the prevention of postoperative recurrence in Crohn\u2019s disease: results of a decision analysis. Am J Gastroenterol. 2011;106:2009\u201317.","journal-title":"Am J Gastroenterol"},{"key":"128_CR71","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1203572","volume":"367","author":"WJ Sandborn","year":"2012","unstructured":"Sandborn WJ, Gasink C, Gao L-L, et al. Ustekinumab induction and maintenance therapy in refractory Crohn\u2019s disease. N Engl J Med. 2012;367:1519\u201328.","journal-title":"N Engl J Med"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-013-0128-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40265-013-0128-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-013-0128-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T18:28:30Z","timestamp":1716056910000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40265-013-0128-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,17]]},"references-count":71,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["128"],"URL":"https:\/\/doi.org\/10.1007\/s40265-013-0128-x","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,17]]}}}